Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients
Veriheal
AUGUST 12, 2021
Patients who suffer from epilepsy , which affects some 3.4 million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). Researchers Analyzed Survey Results from 280 Epilepsy Patients.
Let's personalize your content